Azeliragon for cell activation
Catalog number
B1152-25
Name
Azeliragon for cell activation
Size
25 mg
Price
757.00 EUR
Supplier
Details
Description
Azeliragon is a potent RAGE (the receptor for advanced glycation end products) inhibitor. It has been evaluated for potential treatment for patients with mild-to-moderate Alzheimer's disease (AD). Azeliragon decreases brain amyloid in mice and improves their performance on behavior tests. Azeliragon is a promising agent for for Alzheimer's disease and cerebral amyloid angiopathy.
Peptide sequence
N/A
CAS number
603148-36-3
Molecular weight
532.12
Category
Biochemicals
Other name
3-(4-(2-butyl-1-(4-(4-chlorophenoxy)phenyl)-1H-imidazol-4-yl)phenoxy)-N,N-diethylpropan-1-amine; TTP488; TTP-488
Molecular formula
C₃₂H₃₈ClN₃O₂
Physical appearance
Crystalline Solid
Supplied with
N/A
Is this a salt?
No
Is it cell-permeable?
Yes
Purification
≥98% by HPLC
Reconstitute instructions
DMSO (>5 mg/ml)
Storage condition
-20°C
Shipping condition
gel pack
Maximum time for storage
36 months
Storage instructions
Protect from air and light
Tissue
cell
Additional description
For cells, cell lines and tissues in culture till half confluency.
